Retero Life Sciences Private Limited

Retero Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24304TG2018PTC121898 Incorporated 17 January 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹1.8 Cr
▼ 55.50% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Last financials
Mar 2025
Balance sheet date

About Retero Life Sciences Private Limited

Data last updated: 09 February 2026

Retero Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 17 January 2018, the company has been in operation for over 8 years.

Registered with ROC Hyderabad under CIN U24304TG2018PTC121898.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sambasivarao Narra and Narra Kavitha.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: No: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.8 Cr, a decline of 55.5% compared to the previous year.

The company is associated with 1 brand - Retero Life Sciences. As per MCA filings, the company has open charges of ₹1 Cr on record.

Company Details of Retero Life Sciences Private Limited
CIN U24304TG2018PTC121898
Registration Number 121898
Incorporation Date 17 January 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    No: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038
  • Industry
    Pharma, API Manufacturers
Company report
Retero Life Sciences Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Retero Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Retero Life Sciences Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Retero Life Sciences Private Limited

Retero Life Sciences Private Limited operates one associated brand: Retero life sciences. These brands represent Retero Life Sciences Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Functions as a CDMO focused on API intermediates manufacturing. reterolifesciences.com

Competitors & Alternatives of Retero Life Sciences Private Limited

Brands and companies operating in the same space as Retero Life Sciences Private Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.

Competitor Description Location Founded
Inventys Inventys Actives, advanced intermediates, and specialty chemicals are custom manufactured. Mumbai, India, India 2005
Viyash Viyash APIs and intermediates are manufactured by Viyash as a CDMO. Hyderabad, India, India 2019
Blue Jet Healthcare Blue Jet Healthcare CDMO focused on manufacturing, supplier, and development of intermediates & APIs Mumbai, India, India 1969
Ami organics Ami organics Advanced API intermediates are manufactured for pharmaceutical use. Surat, India, India 2007
Aparna Pharmaceuticals Aparna Pharmaceuticals API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. Hyderabad, India, India 2008
HuiSheng Biotech Pharmaceutical HuiSheng Biotech Pharmaceutical APIs, intermediates, and finished dosage forms are manufactured. Hangzhou, China, China 2004
DUDE CHEM DUDE CHEM CDMO focused on manufacturing of APIs and intermediates Berlin, Germany, Germany 2019
Enanti Labs Enanti Labs Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. Hyderabad, India, India 2007
Hindys Lab Hindys Lab Manufactures and exports pharmaceutical intermediates for global markets. Hyderabad, India, India 2007

Business Activity of Retero Life Sciences Private Limited

Retero Life Sciences Private Limited operates primarily in the hospital and medical care sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Hospital and Medical Care Locked Other Hospital and Medical Care Activities Locked
Premium access

Detailed business activity records for Retero Life Sciences Private Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Retero Life Sciences Private Limited

Retero Life Sciences Private Limited is audited by G V M K & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
G V M K & CO Locked Locked Locked
Premium access

Complete auditor history for Retero Life Sciences Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Retero Life Sciences Private Limited

Retero Life Sciences Private Limited is currently managed by 2 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sambasivarao Narra Director 16 Jul 2019 7 Years 1 Months Current
Narra Kavitha Director 15 Apr 2022 4 Years 4 Months Current

Financials of Retero Life Sciences Private Limited FY 2025 filings available

Retero Life Sciences Private Limited reported revenue of ₹1.8 Cr (down 55.50% YoY) for FY 2023.

Revenue · FY 2023
₹1.8 Cr ▼ 55.50%
Premium access

Ten-year financial statements for Retero Life Sciences Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Retero Life Sciences Private Limited

Premium access

Shareholding and ownership data for Retero Life Sciences Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Retero Life Sciences Private Limited

Open charges
₹1 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹1.00 Cr
Latest charge details
DateLenderAmountStatus
25 Sep 2025 Others ₹1 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Retero Life Sciences Private Limited

View historical data on people associated with Retero Life Sciences Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Retero Life Sciences Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Retero Life Sciences Private Limited

Premium access

GST registrations and filing compliance for Retero Life Sciences Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Retero Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Retero Life Sciences Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Retero Life Sciences Private Limited

Premium access

MSME payment history for Retero Life Sciences Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Retero Life Sciences Private Limited

Premium access

Corporate group structure for Retero Life Sciences Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Retero Life Sciences Private Limited

Premium access

MCA filings and documents for Retero Life Sciences Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Retero Life Sciences Private Limited

Activity
30 Sep 2025
Retero Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
25 Sep 2025
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 101170955 was registered on 25 Sep 2025.
Activity
31 Mar 2025
Retero Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
15 Apr 2022
Narra Kavitha was appointed as a Director on 15 Apr 2022 & has been associated with this company since 4 years 4 months.
Directors
16 Jul 2019
Sambasivarao Narra was appointed as a Director on 16 Jul 2019 & has been associated with this company since 7 years 1 month.
Activity
17 Jan 2018
Retero Life Sciences Private Limited was registered on 17 Jan 2018 with Roc Hyderabad & aged 8 years 7 months as per MCA records.

Frequently Asked Questions about Retero Life Sciences Private Limited

Retero Life Sciences Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 17 January 2018 (8+ years old) and is registered under CIN U24304TG2018PTC121898.

Retero Life Sciences Private Limited reported revenue of ₹1.8 Cr for FY 2023 (down 55.50% YoY).

The current directors of Retero Life Sciences Private Limited are:

The primary industry of Retero Life Sciences Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Retero Life Sciences Private Limited can be reached at the registered office: No: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available